Rosuvastatin 10 mg (Tab)

Product Overview

YASROVEX-10 is a high-potency cardiovascular formulation containing Rosuvastatin 10 mg. Featuring a hydrophilic competitive HMG-CoA reductase inhibitor, it binds directly to the active catalytic site of the enzyme to inhibit hepatic cholesterol synthesis far more potently per milligram than traditional statins. Its high hepatic selectivity enhances LDL uptake, decreases inflammatory markers like C-reactive protein (CRP), halts atheromatous plaque progression, and maintains vascular endothelial integrity.
Designed for potent arterial care, this daily medication stops the liver from making extra cholesterol while pulling existing bad cholesterol out of the blood. It calms blood vessel inflammation and prevents arteries from narrowing or hardening over time.
Developed under stringent quality standards, YASROVEX-10 ensures consistent efficacy, safety, and patient compliance — empowering physicians to achieve optimal therapeutic outcomes in Hypercholesterolemia and Atherosclerosis Prevention.

Potent LDL and triglyceride reduction with marked HDL elevation.
Demonstrated superiority in lipid profile improvement compared to other statins.
Reduces risk of myocardial infarction, stroke, and revascularization procedures.
Excellent tolerability and once-daily convenience for long-term therapy.

Each film-coated tablet contains:

Offers powerful lipid control for high-risk cardiovascular patients.
Provides early and sustained therapeutic response with minimal side effects.
Supports arterial plaque stabilization and vascular function improvement.
Clinically proven to reduce major cardiovascular events in long-term trials.

Part of Yaselle Cardiora – Cardiac & Hypertension Care Division
Protecting every heartbeat with science and care.